跳至主要内容
临床试验/EUCTR2018-004802-24-NL
EUCTR2018-004802-24-NL进行中(未招募)1 期

Optimizing timing of glucocorticoid treatment in children with congenitaladrenal hyperplasia - OPTIMED study

Radboud University Nijmegen Medical Centre0 个研究点目标入组 50 人开始时间: 2019年5月13日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children with CAH due to 21-hydroxylase deficiency > 4 years old and
  • < 18 years old
  • The diagnosis is confirmed by mutation analysis
  • Patient are treated with hydrocortisone according to standard
  • guidelines in a thrice daily schedule
  • Ability to collect saliva
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 50
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Other forms of CAH
  • Not able to collect saliva
  • Chronical medication use other than hydrocortisone and
  • fludrocortisone

研究者

发起方
Radboud University Nijmegen Medical Centre

相似试验